Translational Neurodegeneration Q1
Unclaimed
BioMed Central Ltd.
United Kingdom
Translational Neurodegeneration is a journal indexed in SJR in Neurology (clinical) and Cellular and Molecular Neuroscience with an H index of 54. It is an CC BY + CC0 Journal with a Single blind Peer Review review system, and It has a price of 2390 €. The scope of the journal is focused on neurodegenerative diseases, dementia, motor neurone disease, Parkinson's disease, Alzheimer's disease. It has an SJR impact factor of 2,571 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,571.
Type: Journal
Type of Copyright: CC BY + CC0
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -



Price
2390 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
2,571
SJR Impact factor54
H Index54
Total Docs (Last Year)129
Total Docs (3 years)6294
Total Refs1382
Total Cites (3 years)124
Citable Docs (3 years)10.88
Cites/Doc (2 years)116.56
Ref/DocOther journals with similar parameters
The Lancet Neurology Q1
JAMA Neurology Q1
Nature Reviews Neurology Q1
Molecular Neurodegeneration Q1
Acta Neuropathologica Q1
Compare this journals
Aims and Scope
Neurodegenerative diseases
Dementia
Motor neurone disease
Parkinson's disease
Alzheimer's disease
Comments